News & Updates
Filter by Specialty:
Pulse vs nonpulse corticosteroid: Which is better against IPF?
Patients with acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) who received a pulse dose of corticosteroids do not appear to have longer survival than those who received conventional nonpulse dose of corticosteroids, results of a study have shown.
Pulse vs nonpulse corticosteroid: Which is better against IPF?
07 Mar 2024
Lipoprotein(a) predicts MACE in patients with or without ASCVD
Increased lipoprotein(a) (Lp[a]) appears predictive of long-term major adverse cardiovascular events (MACE) in people with and without baseline atherosclerotic cardiovascular disease (ASCVD), according to a recent study.
Lipoprotein(a) predicts MACE in patients with or without ASCVD
07 Mar 2024
Needle-free epinephrine an alternative for anaphylaxis?
In a study presented at AAAAI 2024, epinephrine in preservative-free, nasal powder formulations demonstrated superior stability and comparable plasma exposure to the EpiPen® autoinjector, thus providing a less-invasive treatment option for severe allergic reactions including anaphylaxis.
